The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study.

Cordone I, Marchesi F, Masi S, Summa V, Pisani F, Merola R, Cigliana G, Orlandi G, Gumenyuk S, Palombi F, Romano A, Spadea A, Renzi D, Papa E, Canfora M, Conti L, Petti MC, Mengarelli A. J Exp Clin Cancer Res. 2016 Mar 19;35(1):49. doi: 10.1186/s13046-016-0324-0. PMID: 26992692 [PubMed - in process] Free PMC Article READ MORE

Posted: April 28, 2016

Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.

Chon HJ, Lee Y, Bae KJ, Byun BJ, Kim SA, Kim J. Amino Acids. 2016 Mar 19. [Epub ahead of print] PMID: 26995282 [PubMed - as supplied by publisher] READ MORE

Posted: April 28, 2016

Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.

Park J, Park E, Jung CK, Kang SW, Kim BG, Jung Y, Kim TH, Lim JY, Lee SE, Min CK, Won KA. BMC Cancer. 2016 Mar 24;16(1):247. doi: 10.1186/s12885-016-2285-2. PMID: 27012957 [PubMed - in process] Free PMC Article READ MORE

Posted: April 28, 2016

Page 29 of 87« First...1020...2728293031...405060...Last »